Shield Therapeutics PLC banner

Intrinsic Value

The intrinsic value of Shield Therapeutics PLC (SHIEF) under the Base Case is 0.0856 USD per share. Compared with the current market price of 0.0413 USD, the stock appears Undervalued by 52% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

SHIEF Intrinsic Value
$0.0856
Undervaluation 52%
Intrinsic Value
Price $0.0413

SHIEF is cheaper than usual. It was this cheap or cheaper on just 4% of days in the past 5 years.

Alert me when SHIEF is below its intrinsic value
Today $0.0685 · Already reached, the price is 39.7% below it
Alternatives to SHIEF

Fundamental Analysis

What Shield Therapeutics Does

Pharmaceuticals Health Care

Shield Therapeutics is a specialty pharmaceutical company focused on treating iron deficiency and iron deficiency anaemia. Its main product is an oral iron medicine designed for patients who cannot tolerate standard iron pills or who need a different way to replace iron. The company sells prescription medicine to healthcare providers and pharmacies, so the real customers are doctors, hospitals, and patients using the treatment under medical supervision.

Headquarters
United Kingdom UK
Employees
63
IPO date
Feb 26, 2016
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue SHIEF Research

Decided on Shield Therapeutics? Get an email when SHIEF reaches the price you’d buy at. Free with an account.

Other Shield Therapeutics listings

What is the Intrinsic Value of one SHIEF stock?

The intrinsic value for Shield Therapeutics PLC (SHIEF) under the Base Case is 0.0856 USD.

Is SHIEF stock undervalued or overvalued?

Compared with the current market price of 0.0413 USD, the stock appears Undervalued by 52% .

How reliable are our estimates? See how past valuations played out
Back to Top